1Kraft A,Weindel K,Ochds A,et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease[J]. Cancer,1999,85(1):178-187.
2Van BE,Tio FO,chen D,et al.Passivatiouof metallic stents afear arterial gene transfer of phVEGF 165 inhibits thrombus for-mation and intimal thickening.J Am coll cardiol,1997,29:1371
3Lopez JJ,Laham KJ,Stamler A,et al VEGF administration in chronic myocardial ischemia in pigs.Cardiovasc Res,1998,40:272-281
4Takeshitas,Tsurumi Y,Isner JM,et al.Gene transfer of na-kea DNA encoding for three isforms of vasculal endothelial growth factor stim ulates collateral deceloomentin vivo.Lab In-vest,1996,75:487
5Tsurclmi Y,Takeshita S,Isner JM,et al.Direct intramuscular gene transfer of naked DNA en coding vasculal endothelial growth factor clugments collateral levelopment and tissue perfusion.Circ-ulation,1996,94:3281
6Magorern CJ,Mack CA,Zhang J,et al.Di-rectin vivo gene transfer canine myocardi-um using a replication-deficieut adenovirus vector.Ann Thorac surg,1996,62:425-434
7Mack CA,patel SR,Schwarz EA.Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary de-oxyribonucleic acid for vascular endothelial growth factor 121 improves myoxardial perfusion and function in the isdemic porcine heart.J Th orac cardidasc surg,1998,115:168-177
8Mack CA,Magovekn CJ,Budenbender KT.Saluvge an-giogenesis induced by adenovirusmediated gene transfer of vascular endothelial growth factor protects against ischemic vas-cular oclusion.J Vasc Surg,1998,27:699-713
9Hemy T,Rocha SK,Isner J,et al.Results of introacornary recombinant human vascular endothelial grouth factor administration trial.J Am Coll cardiol,1998,31(suppl):2A:65A
10Baumgartner I,Pieczek A,Manor O,et al.Contitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel decelop ment in patients with critical limb.Ischemia.Circulation,1998,97:1114-1123
1Hui AM, Kanai Y, Sakamogto M, et al. Reduced p21[WAF1/CIP1] expression and p53 mutation in hepatocellular carcinoma [J]. Hepatology, 1997, 25: 575.
2Zolota V, Batistatou A, Tsamandas A, et al. Immunohistochemical expression of TGF-betal, p21WAF1, p21WAF1, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study [ J]. Int J Gastrointest Cancer, 2003, 32 : 83 -90.
3Hui AM, Kanai Y, Sakamogto M, et al. Reduced p21 [WAF1/ CIP1] expression and p53 mutation in hepatocellular carcinoma [J].Hepatology, 1997, 25: 575.
4Michieli P, Chedid M, Lin D, et al. Induction of WAF/CIP1 by a p53-independent pathway[J].Cancer Res, 1995, 5:884-888.
5Steinman RA, Johnson DE. p21WAF1 prevents down- modulation of the apoptotie inhibitor protein e - IAP1 and inhibits leukemic apoptosis[J].MolMed, 2000, 6: 736-749.
